Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Organon & Co. (OGN)

Organon & Co. (OGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Organon To Report First Quarter 2026 Results and Host Conference Call on May 7, 2026 Business Wire - Thu Apr 16, 6:30AM CDT

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, will release its first quarter 2026 financial results on May 7, 2026,...

OGN : 9.14 (+3.39%)
Organon’s VTAMA® (tapinarof) cream, 1%, Granted Strong Recommendation in the 2026 American Academy of Dermatology Guidelines for Pediatric Atopic Dermatitis Business Wire - Wed Apr 15, 6:30AM CDT

The American Academy of Dermatology (AAD) provided a strong, evidence-based recommendation for the use of VTAMA cream, the only steroid-free topical treatment the AAD found to be supported by a high certainty...

OGN : 9.14 (+3.39%)
OGN
3 Reasons to Avoid OGN and 1 Stock to Buy Instead StockStory - Sun Apr 12, 11:05PM CDT

3 Reasons to Avoid OGN and 1 Stock to Buy Instead

OGN : 9.14 (+3.39%)
Wall street sign in New York with New York Stock Exchange background by Stuart Monk via Shutterstock
S&P Futures Waver With All Eyes on Key U.S. Inflation Data, U.S.-Iran Talks Awaited Barchart - Fri Apr 10, 5:27AM CDT

June S&P 500 E-Mini futures (ESM26) are trending down -0.02% this morning, swinging between gains and losses as investors cautiously await key U.S. inflation data to gauge the impact of higher oil prices...

ESM26 : 7,162.75 (-0.12%)
ADSK : 247.57 (+0.85%)
BF.B : 28.53 (-0.77%)
OGN : 9.14 (+3.39%)
NOW : 103.07 (+2.93%)
ZS : 142.66 (+2.18%)
BC.M.DX : 86.440 (-0.40%)
NKE : 45.68 (-1.53%)
SW.FP : 42.280 (-1.54%)
LITE : 873.60 (+4.38%)
AMZN : 255.36 (+2.18%)
MRVL : 157.32 (+3.97%)
GH
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know StockStory - Mon Apr 6, 2:30PM CDT

Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know

FTRE : 10.50 (+1.74%)
GH : 89.56 (-0.89%)
OGN : 9.14 (+3.39%)
CRL : 184.80 (+0.93%)
QDEL : 11.90 (-1.16%)
Organon accelerates Women's Health progress across Asia Pacific with 2026 Her Health Grants PR Newswire - Sun Mar 29, 5:27PM CDT

SYDNEY , March 27, 2026 /PRNewswire/ -- Organon Asia Pacific Cluster today announced the 2026 Her Health Grant recipients for the Asia Pacific region, marking a significant milestone in efforts to...

OGN : 9.14 (+3.39%)
Organon Debuts New Analysis of VTAMA® (tapinarof) cream, 1%, Phase 3 Pooled Data Demonstrating Early and Consistent Skin Clearance and Itch Improvement in Atopic Dermatitis Patients Down to 2 Years of Age Business Wire - Fri Mar 27, 7:00AM CDT

VTAMA demonstrated early and consistent response rates in disease severity and itch improvements, measured by the Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™) and Peak Pruritus-Numeric...

OGN : 9.14 (+3.39%)
CPB
3 Cash-Producing Stocks We’re Skeptical Of StockStory - Sun Mar 22, 11:36PM CDT

3 Cash-Producing Stocks We’re Skeptical Of

CPB : 20.82 (-0.43%)
TRU : 73.99 (-4.46%)
OGN : 9.14 (+3.39%)
REZI
3 Value Stocks We Approach with Caution StockStory - Thu Mar 19, 11:34PM CDT

3 Value Stocks We Approach with Caution

REZI : 40.57 (+0.72%)
OGN : 9.14 (+3.39%)
PEBO : 33.92 (-1.05%)
LESL
1 Stock Under $10 to Own for Decades and 2 That Underwhelm StockStory - Wed Mar 18, 11:32PM CDT

1 Stock Under $10 to Own for Decades and 2 That Underwhelm

LESL : 2.01 (-1.47%)
GDYN : 5.87 (-0.51%)
OGN : 9.14 (+3.39%)

Barchart Exclusives

This Dividend Stock Keeps Hitting It Out of the Park: Should You Buy? Barchart - 30 minutes ago
Citigroup's financial performance has been impressive over the last couple of years as its transformation under CEO Jane Fraser is bearing fruit. Is the stock a buy? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.